
Please try another search
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company’s lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Name | Age | Since | Title |
---|---|---|---|
Philip T. Sager | 69 | 2020 | Chief Medical Advisor & Member of the Scientific Advisory Board |
John DiMarco | - | - | Member of the Scientific Advisory Board |
Harry A. Kopelman | - | - | Member of the Scientific Advisory Board |
Philippe Douville | 63 | 2005 | Founder, Strategic Advisor & Member of Scientific Advisory Board |
Albert L. Waldo | - | - | Member of the Scientific Advisory Board |
Harry Jefferson Leighton | 79 | - | Member of the Scientific Advisory Board |
Michael John Tomsicek | 59 | 2019 | Independent Non-Executive Director |
Seth H. Z. Fischer | 69 | 2023 | Independent Non-Executive Director |
Stuart M. Duty | 56 | 2024 | Independent Director |
Daniel R. Omstead | 72 | 2017 | Observer |
Joseph C. Papa | 69 | 2024 | Independent Non-Executive Director |
John Camm | - | - | Member of the Scientific Advisory Board |
Jean-Yves Le Heuzey | - | - | Member of the Scientific Advisory Board |
Paul Dorian | - | - | Member of the Scientific Advisory Board |
Lisa M. Giles | 66 | 2020 | Independent Non-Executive Director |
Joseph G. Oliveto | 57 | 2017 | CEO, President & Director |
Peter R. Kowey | - | - | Member of the Scientific Advisory Board |
Robert James Wills | 71 | 2020 | Independent Chairman of the Board |
Andrew R. Saik | 56 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review